Education
About Us
Working with TipRanks
Follow Us
Antibe Therapeutics, Inc. (Otc) (ATBPF)
:ATBPF
| Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 9.71M | C$ 9.99M | C$ 9.54M |
| Gross Profit | C$ 0.00 | C$ -99.00K | C$ 3.55M | C$ 3.89M | C$ 3.55M |
| Operating Income | C$ -20.55M | C$ -25.53M | C$ -24.71M | C$ -18.92M | C$ -12.19M |
| EBITDA | C$ -19.19M | C$ -25.15M | C$ -23.73M | C$ -17.98M | C$ -11.84M |
| Net Income | C$ -19.48M | C$ -25.06M | C$ -26.30M | C$ -19.34M | C$ -12.82M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 38.89M | C$ 54.81M | C$ 72.00M | C$ 6.21M | C$ 6.02M |
| Total Assets | C$ 70.56M | C$ 89.16M | C$ 81.74M | C$ 13.84M | C$ 14.82M |
| Total Debt | C$ 0.00 | C$ 0.00 | C$ 238.00K | C$ 2.40M | C$ 2.07M |
| Net Debt | C$ -6.75M | C$ -34.81M | C$ -71.73M | C$ -3.78M | C$ -3.92M |
| Total Liabilities | C$ 30.39M | C$ 32.33M | C$ 31.48M | C$ 10.06M | C$ 7.38M |
| Stockholders' Equity | C$ 40.17M | C$ 56.83M | C$ 50.26M | C$ 3.78M | C$ 7.44M |
| Cash Flow | |||||
| Free Cash Flow | C$ -16.31M | C$ -16.93M | C$ -105.00K | C$ -11.94M | C$ -7.21M |
| Operating Cash Flow | C$ -16.30M | C$ -16.92M | C$ -105.00K | C$ -11.94M | C$ -7.06M |
| Investing Cash Flow | C$ -11.83M | C$ -20.22M | C$ -264.00K | C$ 98.00K | C$ -257.40K |
| Financing Cash Flow | C$ 80.00K | C$ -26.00K | C$ 66.16M | C$ 12.00M | C$ 9.59M |
Antibe Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.